We are an international group of biotechnology companies with expertise in immunodiagnostics, molecular diagnostics, and radio-immunodiagnostics. Founded in 1992 in the Czech Republic, we have grown from a local company into a global innovator with in-house research, development, and production of in-vitro diagnostic (IVD) products, supported by an international distribution network.
Our strategy is anchored by three key projects – CLIA, MBA, and NGS – focusing our innovation and delivery across next-generation sequencing, chemiluminescent immunoassays, and Microblot-Array. By combining scientific excellence, strong innovation capacity, and a presence in more than 100 markets worldwide, we deliver solutions that advance laboratory practice and patient care, making us one of the key players in clinical diagnostics.